Rotational Analyst

About Roivant Sciences Roivant (Nasdaq: ROIV) is a commercial-stage biopharmaceutical company that aims to improve the lives of patients by accelerating the development and commercialization of medicines that matter. Roivant’s pipeline includes LISRAYA™ (brepocitinib), a potent small molecule inhibitor of JAK1 and TYK2 FDA-approved for the treatment of dermatomyositis in adult patients and also in late-stage development for the treatment of non-infectious uveitis, cutaneous sarcoidosis and lichen planopilaris; IMVT-1402, a fully human monoclonal antibody targeting FcRn in development across several IgG-mediated autoimmune indications; and mosliciguat, an inhaled sGC activator in development for pulmonary hypertension associated with interstitial lung disease. We advance our pipeline by creating nimble subsidiaries or “Vants” to develop and commercialize our medicines and technologies. For more information, visit www.roivant.com . We embrace diversity across all dimensions and levels of the organization, and we strive to ensure every employee is supported in reaching their full potential. We hire motivated people with diverse backgrounds, identities, experiences and skillsets. We are committed to fostering an inclusive culture where all employees feel valued, respected and empowered to create value for patients. About the Rotational Analyst Program Our two-year Rotational Analyst Program begins in July 2027. It offers recent college graduates the opportunity to complete four (4) six-month rotations across different teams and functions, including our portfolio of Vants. The aim of this program is to attract and develop future leaders across the Roivant family by accelerating the development of talent. From day one, analysts will own projects and have opportunities to make a meaningful impact. Now in its seventh year, Rotational Analysts have taken on demanding projects across a wide range of functions at Roivant and the Vants. Sample Projects Include: • Investments: Evaluating in-licensing opportunities to expand Roivant’s portfolio of life changing medicines • Research and Development: Performing literature reviews to identify indication expansion opportunities in support of Vants • Vants: Developing strategies to accelerate clinical trial recruitment • Strategic Finance: Creating an investor deck, in partnership with key executives, for a Phase 3 clinical trial readout Each year, graduates of our Rotational Analyst Program pursue exciting opportunities as full-time employees at Roivant or our Vants. Beyond the Roivant portfolio, RAs have gone on to pursue higher education at top universities. Roivant is a Fast Company Best Workplace for Innovators , with the Rotational Analyst Program recognized as a standout among Science and Technology firms. About You We believe our employees are our most important asset. Our goal is to identify top talent with potential to develop into future leaders across our business. We prioritize intellect and entrepreneurial verve. We offer a fast-paced environment that values work ethic, analytical rigor, collaboration, and creative thinking. At Roivant, we will give you the resources and freedom to tackle some of the most important and challenging problems in healthcare. If you find that exciting, we want to work with you. Below, we’ve listed some preferred characteristics and requirements for our incoming Rotational Analysts. If this sounds like you, please apply today! Preferred Skills & Characteristics • Ambitious & Driven . Passionate about Roivant’s mission to improve health by rapidly delivering innovative medicines to patients, and curious about the intersection between science and technology. • Curious & Analytical . Asks sharp questions and digs into data to find answers; super